10x Genomics, Inc. TXG Asset Acquisition Contingent Consideration Liability Noncurrent
Asset Acquisition Contingent Consideration Liability Noncurrent at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s asset acquisition contingent consideration liability noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s asset acquisition contingent consideration liability noncurrent?
- 10x Genomics, Inc. (TXG) reported asset acquisition contingent consideration liability noncurrent of $1.22M in Q1 2026.